Literature DB >> 18284102

Psychosocial and behavioral correlates of depressed mood among female methamphetamine users.

Shirley J Semple1, Jim Zians, Steffanie A Strathdee, Thomas L Patterson.   

Abstract

Female methamphetamine (meth) users report more depressive symptoms than do males. This study examined psychosocial and behavioral correlates of depressed mood in 146 heterosexual, meth-using women in San Diego, CA. Sixty percent met Beck Depression Inventory (BDI) criteria for moderate to severe depressive symptoms (i.e., higher levels of depressive symptoms); 40% had minimal to mild depressive symptoms (i.e., lower levels of depressive symptoms). The two groups were compared on background characteristics, reasons for meth use, patterns of meth use, psychosocial factors, social and sexual consequences of meth use, and sexual risk behavior. Women with higher levels of depressive symptoms were less likely to be employed, were more likely to use meth to cope with mood, used more grams of meth in a 30-day period, used meth more times per day on a greater number of consecutive days, and were more likely to be binge users of meth. They also scored lower on a measure of self-esteem and higher on measures of impulsivity, social stigma, and social network members' use of meth. In multivariate analyses, lower self-esteem and higher ratings of social network members' use of meth were significant predictors of higher levels of depressive symptoms. Psychosocial and behavioral factors are discussed in terms of treatment protocols for mood regulation and meth abatement in the target population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18284102     DOI: 10.1080/02791072.2007.10399897

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  19 in total

1.  Psychiatric comorbidity in methamphetamine dependence.

Authors:  Ruth Salo; Keith Flower; Anousheh Kielstein; Martin H Leamon; Thomas E Nordahl; Gantt P Galloway
Journal:  Psychiatry Res       Date:  2010-11-04       Impact factor: 3.222

2.  Methamphetamine alters DNMT and HDAC activity in the posterior dorsal medial amygdala in an ovarian steroid-dependent manner.

Authors:  Sarah A Rudzinskas; Jessica A Mong
Journal:  Neurosci Lett       Date:  2018-06-23       Impact factor: 3.046

3.  Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-01       Impact factor: 4.147

4.  Correlates of drug dealing in female methamphetamine users.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  J Urban Health       Date:  2013-06       Impact factor: 3.671

Review 5.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

6.  Toward a Better Understanding of Non-Addicted, Methamphetamine-Using, Men who Have Sex with Men (MSM) in Atlanta.

Authors:  Brian J Dew
Journal:  Open AIDS J       Date:  2010-05-14

7.  Gender Differences in Psychiatric Symptoms among Methamphetamine Dependent Residents in Sober Living Houses.

Authors:  Douglas L Polcin; Raymond Buscemi; Madhabika Nayak; Rachael Korcha; Gantt Galloway
Journal:  Addict Disord Their Treat       Date:  2012-06-01

8.  Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Authors:  Tracy L Hellem; Young-Hoon Sung; Xian-Feng Shi; Marjorie A Pett; Gwen Latendresse; Jubel Morgan; Rebekah S Huber; Danielle Kuykendall; Kelly J Lundberg; Perry F Renshaw
Journal:  J Dual Diagn       Date:  2015

9.  Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors.

Authors:  Taiwo Akindipe; Don Wilson; Dan J Stein
Journal:  Metab Brain Dis       Date:  2014-02-16       Impact factor: 3.584

10.  Polydrug use among IDUs in Tijuana, Mexico: correlates of methamphetamine use and route of administration by gender.

Authors:  Melanie L Rusch; Remedios Lozada; Robin A Pollini; Alicia Vera; Thomas L Patterson; Patricia Case; Stefanie A Strathdee
Journal:  J Urban Health       Date:  2009-06-12       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.